Cancer Driver Drug Interaction Explorer

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Header Abstract Content Author and article information References Comments

Record: found
Abstract: found
Conference Proceedings: found

Is Open Access

Cancer Driver Drug Interaction Explorer

Published

proceedings-article

Author(s): Michael Hartung ¹ ^, , Elisa Anastasi ² , Zeinab M. Mamdouh ³ , Cristian Nogales ⁴ , Harald HHW Schmidt ⁴ , Jan Baumbach ⁵ , Olga Zolotareva ¹ ^, ⁶ , Markus List ⁶

Publication date (Electronic, epreprint): 20 July 2022

Publisher: ScienceOpen

Conference name: RExPO22

Conference date: 2-3 September, 2022

Keywords: drug repurposing, drug prioritization, network analysis, cancer, network medicine

Bookmark

Abstract

Content

Author and article information

Conference

Publisher: ScienceOpen

Publication date (Electronic, epreprint): 20 July 2022

Affiliations

[1 ] Institute for Computational Systems Biology, University of Hamburg, Hamburg, Germany ( https://ror.org/00g30e956)

[2 ] School of Computing, Newcastle University, Newcastle upon Tyne, UK ( https://ror.org/01kj2bm70)

[3 ] Department of Pharmacology and Personalised Medicine, Maastricht University, Maastricht, Netherlands; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt ( https://ror.org/02jz4aj89)

[4 ] Department of Pharmacology and Personalised Medicine, Maastricht University, Maastricht, Netherlands ( https://ror.org/02jz4aj89)

[5 ] Institute for Computational Systems Biology, University of Hamburg, Hamburg, Germany; Computational Biomedicine Lab, Department of Mathematics and Computer Science, University of Southern Denmark, Odense, Denmark;

[6 ] Chair of Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany ( https://ror.org/02kkvpp62)

Author notes

[* ]Email: michael.hartung@ 123456uni-hamburg.de .

Author information

Michael Hartung https://orcid.org/0000-0002-3992-0125

Article

DOI: 10.14293/S2199-1006.1.SOR-.PPPPRSWM.v1

SO-VID: 8e85bd4a-7748-4213-8fa9-c21d2d5d55aa

License:

This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

Conference name: RExPO22

Conference location: Maastricht, Netherlands

Conference date: 2-3 September, 2022

History

Date received : 20 July 2022

Product

ScienceOpen

Funding

Funded by: funder-id http://dx.doi.org/10.13039/100010661, Horizon 2020 Framework Programme;

Award ID: 777111

Data availability: The datasets generated during and/or analysed during the current study are available in the repository: https://github.com/biomedbigdata/CADDIE-backend

Keywords: drug repurposing,drug prioritization,network analysis,cancer,network medicine

References

Hartung Michael, Anastasi Elisa, Mamdouh Zeinab M, Nogales Cristian, Schmidt Harald H H W, Baumbach Jan, Zolotareva Olga, List Markus. Cancer driver drug interaction explorer. Nucleic Acids Research. Vol. 50(W1)2022. Oxford University Press (OUP). [Cross Ref]

Comments

Comment on this article

[1] Hartung Michael, Anastasi Elisa, Mamdouh Zeinab M, Nogales Cristian, Schmidt Harald H H W, Baumbach Jan, Zolotareva Olga, List Markus. Cancer driver drug interaction explorer. Nucleic Acids Research. Vol. 50(W1)2022. Oxford University Press (OUP). [Cross Ref]